Hernan E. Grenett

Biography

 Hernan E. Grenett, Ph.D., is an Associate Professor in the Department of Medicine (Division of Cardiovascular Disease). Dr Grenett is an experienced biochemist/molecular biologist, with extensive experience in molecular cloning, DNA-mediated gene transfer, and gene expression in prokaryotic and eukaryotic cells. He is currently project leader in a program project dealing with the cardioprotective benefit of ethanol and polyphenols. His scientific expertise in vascular biology is well recognized, as exemplified by his being asked to review manuscripts for a number of scientific journals, including the Journal of Thrombosis and Haemostasis, Journal Thrombosis Research, Biochimica et Biophysica Acta, Journal of the American College of Cardiology, and Arteriosclerosis, Thrombosis, and Vascular Biology. He has been internationally sought after as a visiting professor at the Universities of Cadiz, Spain and Antofagasta, Chile. Currently his laboratory is engaged in a novel phamacogenomic approach to molecular pathway analysis in pulmonary arterial hypertension (PAH).  Restenosis and thrombosis that lead to failure in too great a proportion of central and peripheral vascular stent procedures is central to Dr. Grenett’s research with Agenta Biotechnologies, Inc.  As Director of Agenta’s Bioactive Vascular Stent Program, Dr. Grenett will be advancing biotechnology to increase stent re-endothelialization and to decrease thrombus development following stent placement.

Research Interest

biochemist/molecular biologist